This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.bbc.co.uk/news/business-30084329
The article has changed 3 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
Actavis to buy Botox-maker Allergan $66bn | |
(about 17 hours later) | |
Actavis is buying Botox-maker Allergan for $66bn (£42bn) to create one of the top ten biggest pharmaceutical companies in the world. | Actavis is buying Botox-maker Allergan for $66bn (£42bn) to create one of the top ten biggest pharmaceutical companies in the world. |
Allergan had spent months fending off a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals. | Allergan had spent months fending off a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals. |
The cash and shares deal agreed with Actavis is worth about $12bn more than Valeant's offer. | The cash and shares deal agreed with Actavis is worth about $12bn more than Valeant's offer. |
Actavis said the deal would mean $1.8bn in annual cost savings. | Actavis said the deal would mean $1.8bn in annual cost savings. |
The deal between Allergan, which is also the lead supplier of breast implants, and Actavis is the biggest pharmaceutical deal this year. | The deal between Allergan, which is also the lead supplier of breast implants, and Actavis is the biggest pharmaceutical deal this year. |
Allergan had seen the attempted takeover by Valeant as "hostile" and had expressed concerns that Valeant would reduce research and development in order to make the deal work financially. | Allergan had seen the attempted takeover by Valeant as "hostile" and had expressed concerns that Valeant would reduce research and development in order to make the deal work financially. |